Do not delay or change prescribed medication because of an online finance article. Contact the prescriber or pharmacist about continuity and safe options, then check medical-scheme benefits, designated providers and pharmacy pricing. Credit should be considered only after the health question is handled and the full repayment fits your budget.
This page provides financial decision support, not medical advice. Never change a medicine, dose or treatment schedule without guidance from an appropriately qualified healthcare professional.
Handle the clinical question before the price question
If medicine is about to run out, tell the prescriber or pharmacist exactly when the current supply ends. Ask what must happen to avoid an unsafe interruption. A finance comparison cannot decide whether a substitute, different pack size or delayed dose is clinically appropriate.
You can still prepare useful cost questions. Request the medicine name, strength, quantity, repeat status and cash price in writing. If a lower-priced equivalent may exist, ask the pharmacist and prescriber whether it is appropriate for the prescription. Do not make the substitution yourself.
For medical-scheme members, ask whether the medicine falls under a Prescribed Minimum Benefit or Chronic Disease List condition, whether prior authorisation is needed, and which Designated Service Provider applies. The Council for Medical Schemes explains that using a non-designated provider can lead to a co-payment in some circumstances. Coverage depends on diagnosis, scheme rules and the treatment pathway, so confirm the answer with the scheme.
Build a medication-cost comparison
Assume a prescribed 30-day supply has a quoted cash price of R1,200. These numbers are illustrative.
| Route checked | Amount due now | What must be confirmed |
|---|---|---|
| Scheme-designated pharmacy | R250 assumed co-payment | Authorisation, formulary and DSP rules |
| Different pharmacy, same prescription | R900 assumed | Exact medicine, quantity and professional approval |
| Credit-funded cash purchase | R0 at purchase | R1,080 assumed total repayment |
The table is not a recommendation. It shows why checking cover and the dispensing route can change the shortfall before credit is priced. If the verified amount still due is R250, borrowing R900 would create unnecessary debt. If no scheme benefit applies, compare cash quotes only for the same prescribed item and quantity.
For recurring medicine, one credit agreement solves only one month. Add the next refill date to the budget. If next month's medicine still depends on another loan, the plan is not sustainable.
What to ask each party
Healthcare and scheme questions
- What is the safe continuity plan?
- Does authorisation or a DSP rule apply?
- Is a clinically appropriate lower-cost option available?
- Can the provider explain the rejection or co-payment in writing?
Credit questions
- What amount is actually needed after cover?
- What is the total repayment?
- Will repayment affect the next refill budget?
- Is the provider listed in the NCR register?
Do not send prescriptions, identity documents or medical details to a comparison website. If you follow an external provider link, verify its privacy notice and legal identity first. Read our privacy policy, editorial methodology and information-service limits.
When to stop the credit search
Stop when the medicine question is clinically urgent, when you do not know the amount actually payable after scheme processing, or when repayment would threaten food, housing, transport or the next treatment cycle. Contact the healthcare provider, pharmacist or scheme for the clinical and benefit decision.
If existing debt already prevents essential purchases, read the NCR's explanation of debt counselling. It is a regulated process with consequences and costs; verify any counsellor individually.
Sources and review notes
- Council for Medical Schemes: Prescribed Minimum Benefits - official explanation of PMBs, emergencies and designated providers
- NCR Register of Registrants - official credit-provider lookup
- NCR debt-counselling guide - official information for consumers struggling with debt
Sources were accessed on 21 September 2026. Product prices and individual eligibility can change; a provider's formal quotation controls the proposed agreement.